NantHealth Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	67	62.65	73.17	77.43	89.46	86.68	80.4	46.18	33.92
Revenue Growth (YoY)	6.95%	-14.38%	-5.50%	-13.45%	3.22%	7.80%	74.12%	36.13%	-
Cost of Revenue	28.84	27.81	29.23	34.14	44.27	41.52	44.11	20.69	24.23
Gross Profit	38.16	34.84	43.95	43.29	45.2	45.15	36.3	25.49	9.69
Selling, General & Admin	62.5	52.09	48.53	55.6	70.76	74.98	105.26	55.72	46.21
Research & Development	23.05	19.71	17.27	13.93	20.92	33.86	47.31	14.25	16.98
Other Operating Expenses	3.94	3.94	4.41	8.19	4.22	4.22	4.22	0.02	31.18
Operating Expenses	89.49	75.74	70.21	77.72	95.9	113.05	156.79	69.99	94.37
Operating Income	-51.33	-40.9	-26.27	-34.43	-50.7	-67.9	-120.49	-44.5	-84.68
Interest Expense / Income	14.12	14.48	19.2	18.04	17.12	16.17	6.43	0.63	0.98
Other Expense / Income	2.65	2.78	10.41	11.31	128	93.35	80.98	26.5	-1.24
Pretax Income	-68.1	-58.16	-55.88	-63.78	-195.83	-177.41	-207.9	-71.62	-84.42
Income Tax	-0.32	0.1	0.45	-1.02	-3.67	-2.2	-23.8	0.39	0.01
Net Income	-67.78	-58.26	-56.33	-62.76	-192.15	-175.21	-184.1	-72.01	-84.43
Shares Outstanding (Basic)	8	8	7	7	7	8	7	6	5
Shares Outstanding (Diluted)	8	8	7	7	7	8	7	6	5
Shares Change	1.22%	2.87%	0.55%	1.08%	-6.48%	4.60%	25.44%	19.42%	-
EPS (Basic)	-8.80	-7.66	-7.65	-8.55	-26.40	-22.35	-25.35	-14.85	-16.95
EPS (Diluted)	-8.80	-7.66	-7.65	-8.55	-26.40	-22.35	-25.35	-14.85	-16.95
Free Cash Flow	-38.74	-32.77	-22.53	-13.36	-40.18	-94.78	-86.28	-82.24	-49.77
Free Cash Flow Per Share	-5.03	-4.31	-3.04	-1.81	-5.52	-12.18	-11.60	-13.87	-10.02
Gross Margin	56.96%	55.61%	60.06%	55.91%	50.52%	52.10%	45.14%	55.20%	28.57%
Operating Margin	-76.61%	-65.28%	-35.90%	-44.47%	-56.67%	-78.34%	-149.85%	-96.36%	-249.64%
Profit Margin	-101.16%	-92.99%	-76.98%	-81.06%	-214.78%	-202.14%	-228.97%	-155.95%	-248.89%
Free Cash Flow Margin	-57.81%	-52.31%	-30.78%	-17.25%	-44.91%	-109.35%	-107.30%	-178.11%	-146.73%
EBITDA	-37.99	-27.96	-19.91	-23.37	-156.35	-133.19	-170.54	-55.21	-67.26
EBITDA Margin	-56.69%	-44.63%	-27.21%	-30.19%	-174.76%	-153.67%	-212.10%	-119.55%	-198.29%
Depreciation & Amortization	15.99	15.72	16.77	22.36	22.36	28.06	30.93	15.79	16.18
EBIT	-53.98	-43.68	-36.68	-45.74	-178.71	-161.25	-201.47	-70.99	-83.44
EBIT Margin	-80.56%	-69.72%	-50.13%	-59.07%	-199.75%	-186.03%	-250.57%	-153.74%	-245.98%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).